Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV lot-to-lot consistency study of TY flu versus Vaxigrip in healthy Chinese subjects aged 3 years and older
ChiCTR-PRC-12003402Phase 4Completed
- Sponsor
- Tianyuan Bio-Pharmaceutical
- Start
- Sep 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of influenza vaccine in influenza (3 arms), sponsored by Tianyuan Bio-Pharmaceutical. Primary endpoints: Immunogenicity by hemagglutination inhibition assay against each vaccine strain and Lot-to-lot equivalence of post-vaccination GMTs. Started Sep 2012; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR-PRC-12003402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRC-12003402.